Strategy
MSTR
MARA Holdings
MARA
Tesla
TSLA
Coinbase
COIN
Apple
AAPL
US Stock MarketDetailed Quotes
BMRN Biomarin Pharmaceutical
- 71.160
- +2.040+2.95%
Close Feb 28 16:00 ET
- 71.160
- 0.0000.00%
Post 20:01 ET
13.58BMarket Cap32.20P/E (TTM)
71.220High69.120Low1.29MVolume69.250Open69.120Pre Close90.84MTurnover0.72%Turnover Ratio32.20P/E (Static)190.78MShares94.85052wk High2.40P/B12.71BFloat Cap60.63052wk Low--Dividend TTM178.60MShs Float151.750Historical High--Div YieldTTM3.04%Amplitude3.570Historical Low70.675Avg Price1Lot Size
About Biomarin Pharmaceutical Company
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Company Profile
SymbolBMRN
Company NameBiomarin Pharmaceutical
Listing DateJul 23, 1999
Issue Price13.00
Founded1997
CEOMr. Alexander Hardy
MarketNASDAQ
Employees3040
Fiscal Year Ends12-31
Address770 Lindaro Street
CitySan Rafael
ProvinceCalifornia
CountryUnited States of America
Zip Code94901
Phone1-415-506-6700
Websitehttp://www.biomarin.com
Company Executives
- Name
- Position
- Salary
- Alexander Hardy
- Director, President and Chief Executive Officer
- 17.88M
- G. Eric Davis
- Executive Vice President, Chief Legal Officer and Secretary
- --
- Dr. Greg Friberg
- President, Chief Worldwide Research and Development Officer
- --
- Charles Greg Guyer
- Chief Technical Officer and Executive Vice President
- 5.70M
- Brian R. Mueller
- Chief Financial Officer and Executive Vice President, Finance
- 4.85M
- Erin Burkhart
- Group Vice President and Chief Accounting Officer
- --
- Richard A. Meier
- Chairman of the Board
- 515.44K
- Elizabeth McKee Anderson, M.B.A.
- Independent Director
- 480.44K
- Dr. Elaine J. Heron,PhD
- Independent Director
- 486.44K
- Dr. Willard H. Dere, M.D.
- Independent Director
- 480.44K
- Dr. Maykin Ho, PhD
- Independent Director
- 473.94K
- Dr. Athena Countouriotis, M.D.
- Independent Director
- 213.38K
- Timothy P. Walbert
- Independent Director
- --
- Barbara W. Bodem
- Independent Director
- 213.38K
- Robert J. Hombach
- Independent Director
- 486.94K
- David E.I. Pyott, M.B.A.,M.D.
- Independent Director
- 470.44K
- Mark Joseph Enyedy
- Independent Director
- 213.38K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.